InvestorsHub Logo
icon url

Boot Hill

05/05/15 2:23 PM

#27063 RE: chrisduo #27060

What?
icon url

trade4money

05/05/15 2:31 PM

#27071 RE: chrisduo #27060

1 billion OS @ .50 = 500 mil market cap.

Sales of radiogel projected to be 100 mil annually. Modestly priced at 5x revs = $.50

http://ceolive.tv/galena-biopharma/gale-news-events/650-consider-these-three-companies-for-new-innovations-in-cancer-treatment-admd-gale-dcth#readabilityFootnoteLink-4

sales for the radiogel treatment could reach $75 million to $100 million annually



JMO
icon url

DiamondFire

05/05/15 2:42 PM

#27081 RE: chrisduo #27060

...i hear you, but check out this website i just found.

Its a new Biotech ETF that was set up last year. They only invest in two groups of Biotech stocks: ones that are still in Clinical Trials - which as we all know takes years.....and the other group are those companies that have biotech approved products:

http://bioshares.com


...i just went to my charts, choose randomly tickers from each side (after of course hitting each tab to see the tickers) and on the side of Clinical Trials i found Market Caps many still over $500 million to over a Billion. On the 'approved and selling' side i found ones w Market Caps most all over a Billion.


The incredible thing here with ADMD, is that the initial Clinical Trials from the '80's and '90's are over for their Y-90 therapies -- we are just waiting on FDA to be Cleared for what category they should be classified under when hits medical market.

ADMD's Market Cap now is under $10 million.......and we arent waiting on some FDA approved bandages, side treatments, lotions etc...we are waiting on cancer killing new Modern day radioactive isotope Y-90 novel therapies: upon approval they will have a more exciting and modern/revolutionary biotech product then some Nasdaq biotechs(!!) .....let alone huge advantage over all those Naz biotechs still in Clinical Trials w no product.....yet their Market Caps are again in the hundreds of million of dollars.


Man, the opportunity here is immense in long run. Cause yes everyone will profit take on way up with approval, but in time ADMD should attract big biotech Naz money in the following months, to bring its Market Cap up to at least $100 mil ....which would be still waaaay less then Naz biotechs with cancer killing new and modern products on the market.